Bold Capital logo

Bold Capital

Crunchbase
Pitchbook
Crunchbase

Deals on record

7

Common Fundraising Type

Equity

Immunis logo
Immunis

Biotech

Remiges Ventures logo
LifeSpan Vision Ventures logo
JLS Fund logo
Continuum Health Ventures logo
BOLD Capital Partners logo

Immunis, Inc. is a biotech company developing stem cell-derived biologics to treat age-related muscle atrophy and metabolic dysfunction.

Series A
$25M
01/11/2025
Article
Rembrand logo
Rembrand

AI-powered advertising

super{set} logo
The Trade Desk logo
Naver Corporation logo
Greycroft logo
BOLD logo

Rembrand develops AI-powered advertising solutions that integrate brands into video content through In-Scene Media and Virtual Product Placement technology, particularly for the Connected TV market.

Series A
$23M
01/02/2025
Article
OpenPad AI logo
OpenPad AI

Decentralized AI

OpenPad AI specializes in decentralized AI analytics to provide data-driven investment strategies with a focus on user privacy and decentralized control.

Equity
$2M
12/04/2024
Article

Abolis Biotechnologies develops industrial solutions using microorganisms to support sustainable production models.

Equity
$38.7M
09/13/2024
Article

Discure Technologies develops a bioelectronic implantable device aimed at regenerating discs to treat degenerative disc disease.

Series A
$11M
09/10/2024
Article
Debut logo
Debut

Synthetic biology

BOLD logo

Debut is a synthetic biology company that aims to revolutionize the fragrance industry by developing bio-identical and novel fragrance molecules using advanced biomanufacturing processes.

Series B
$40M
10/19/2023
Article
Mighty Buildings logo
Mighty Buildings

3D-Printed Construction

Waed Ventures logo
Khosla Ventures logo
Bold Capital logo

Mighty Buildings is a startup that specializes in creating 3D-printed prefab homes, providing a prefabricated kit of parts to developers, with a material that is stronger than concrete, lighter, and produces fewer carbon emissions.

Equity
$52M
09/12/2023
Article